CN116531447A - Antibacterial liquid and preparation method thereof - Google Patents
Antibacterial liquid and preparation method thereof Download PDFInfo
- Publication number
- CN116531447A CN116531447A CN202310673872.3A CN202310673872A CN116531447A CN 116531447 A CN116531447 A CN 116531447A CN 202310673872 A CN202310673872 A CN 202310673872A CN 116531447 A CN116531447 A CN 116531447A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- antibacterial liquid
- lutein
- preparing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 46
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 241000628997 Flos Species 0.000 claims abstract description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 27
- 229960005375 lutein Drugs 0.000 claims abstract description 22
- 239000001656 lutein Substances 0.000 claims abstract description 22
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims abstract description 22
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims abstract description 22
- 235000012680 lutein Nutrition 0.000 claims abstract description 22
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims abstract description 22
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims abstract description 22
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 17
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000010231 banlangen Substances 0.000 claims abstract description 17
- 229940116229 borneol Drugs 0.000 claims abstract description 17
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 17
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000008213 purified water Substances 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 16
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 12
- 241000928504 Centipeda minima Species 0.000 claims abstract description 12
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 12
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 12
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 12
- 241000334154 Isatis tinctoria Species 0.000 claims abstract description 12
- 240000002262 Litsea cubeba Species 0.000 claims abstract description 12
- 235000012854 Litsea cubeba Nutrition 0.000 claims abstract description 12
- 244000246386 Mentha pulegium Species 0.000 claims abstract description 12
- 235000016257 Mentha pulegium Nutrition 0.000 claims abstract description 12
- 235000004357 Mentha x piperita Nutrition 0.000 claims abstract description 12
- 229960002152 chlorhexidine acetate Drugs 0.000 claims abstract description 12
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 12
- 235000001050 hortel pimenta Nutrition 0.000 claims abstract description 12
- 235000011477 liquorice Nutrition 0.000 claims abstract description 12
- MCSINKKTEDDPNK-UHFFFAOYSA-N propyl propionate Chemical compound CCCOC(=O)CC MCSINKKTEDDPNK-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000009636 Huang Qi Substances 0.000 claims abstract description 11
- 230000003385 bacteriostatic effect Effects 0.000 claims abstract description 8
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims abstract description 8
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 30
- 239000011812 mixed powder Substances 0.000 claims description 20
- 238000007873 sieving Methods 0.000 claims description 20
- 239000003814 drug Substances 0.000 claims description 15
- 241000723353 Chrysanthemum Species 0.000 claims description 11
- 239000000284 extract Substances 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 10
- 238000002791 soaking Methods 0.000 claims description 10
- 240000000691 Houttuynia cordata Species 0.000 claims description 9
- 241000045403 Astragalus propinquus Species 0.000 claims description 6
- 235000013719 Houttuynia cordata Nutrition 0.000 claims description 6
- 241000951473 Schizonepeta Species 0.000 claims description 6
- 235000006533 astragalus Nutrition 0.000 claims description 6
- 241000894006 Bacteria Species 0.000 claims description 5
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 claims description 5
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000000643 oven drying Methods 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 235000013717 Houttuynia Nutrition 0.000 claims description 3
- 238000000034 method Methods 0.000 claims 6
- 244000111489 Gardenia augusta Species 0.000 claims 3
- 230000000694 effects Effects 0.000 abstract description 8
- 241000222122 Candida albicans Species 0.000 abstract description 5
- 241000588724 Escherichia coli Species 0.000 abstract description 5
- 241000191967 Staphylococcus aureus Species 0.000 abstract description 5
- 229940095731 candida albicans Drugs 0.000 abstract description 5
- 206010003399 Arthropod bite Diseases 0.000 abstract description 4
- 206010019233 Headaches Diseases 0.000 abstract description 4
- 208000004356 Hysteria Diseases 0.000 abstract description 4
- 208000000592 Nasal Polyps Diseases 0.000 abstract description 4
- 208000012839 conversion disease Diseases 0.000 abstract description 4
- 231100000869 headache Toxicity 0.000 abstract description 4
- 206010022000 influenza Diseases 0.000 abstract description 4
- 208000014674 injury Diseases 0.000 abstract description 4
- 208000016366 nasal cavity polyp Diseases 0.000 abstract description 4
- 201000009240 nasopharyngitis Diseases 0.000 abstract description 4
- 206010039083 rhinitis Diseases 0.000 abstract description 4
- 239000002341 toxic gas Substances 0.000 abstract description 4
- 230000008736 traumatic injury Effects 0.000 abstract description 4
- 230000003612 virological effect Effects 0.000 abstract description 4
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 3
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 241000157835 Gardenia Species 0.000 description 6
- 210000003928 nasal cavity Anatomy 0.000 description 6
- 241000233866 Fungi Species 0.000 description 1
- 241001316086 Novocrania Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000002184 nasal cartilage Anatomy 0.000 description 1
- 210000000492 nasalseptum Anatomy 0.000 description 1
- 210000001989 nasopharynx Anatomy 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/538—Schizonepeta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
- A61K36/835—Aquilaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
- A61K36/855—Clerodendrum, e.g. glorybower
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The invention discloses a bacteriostatic liquid and a preparation method thereof, and relates to the technical field of bacteriostatic liquids, wherein the bacteriostatic liquid comprises the following raw material components in parts by weight: 2-4 parts of centipeda minima, 2-4 parts of rhizoma atractylodis, 4-6 parts of honeysuckle, 4-6 parts of fructus forsythiae, 2-4 parts of flos magnoliae, 2-4 parts of litsea cubeba, 2-4 parts of peppermint, 3-4 parts of agilawood, 4-6 parts of radix sileris, 4-6 parts of herba schizonepetae, 2-4 parts of liquorice, 5-7 parts of chrysanthemum, 5-6 parts of dyers woad leaf, 4-6 parts of radix isatidis, 2-4 parts of lutein, 4-6 parts of radix astragali, 4-6 parts of radix tetrastigme, 4-6 parts of herba houttuyniae, 4-6 parts of fructus gardeniae, 12-18 parts of purified water, 3-5 parts of chlorhexidine acetate and 0.8-1.2 parts of borneol. The antibacterial liquid adopts natural traditional Chinese medicines as raw material components, is green and safe, has the effects of inhibiting staphylococcus aureus, escherichia coli and candida albicans, can effectively treat various rhinitis, nasosinusitis and nasal polyp, can also treat influenza, common cold and various viral cold, can also prevent hysteria and toxic gas in four seasons, and has certain curative effects on headache, traumatic injury and mosquito bite.
Description
Technical Field
The invention relates to the technical field of antibacterial liquid, in particular to antibacterial liquid and a preparation method thereof.
Background
The nasal cavity is a cavity gap between two lateral crania, and is formed by taking the osseous nasal cavity and cartilage as the basis, and the surface is lined with mucous membrane and skin. The nasal cavity is an irregular long and narrow cavity with wide top and bottom and larger front and rear diameters than the left and right sides, and the anterior naris is lifted forward, and the posterior naris is stopped to open the nasopharynx. The nasal cavity is divided into a left cavity and a right cavity by the nasal septum, the front part is communicated with the outside through nostrils, and the rear part is communicated with the pharyngeal cavity through the rear nasal hole. The nasal cavity is one of the ways in which bacteria, viruses, fungi or some other antigens enter the human body. It is therefore desirable to keep the nasal cavity healthy.
At present, no antibacterial liquid which can inhibit staphylococcus aureus, escherichia coli and candida albicans, can effectively treat various rhinitis, nasosinusitis and nasal polyp, can also treat influenza cold, common cold and various viral cold, can also prevent hysteria and toxic gas in four seasons and has a certain curative effect on headache, traumatic injury and mosquito bite.
Disclosure of Invention
Aiming at the defects in the prior art, the invention provides a bacteriostatic liquid and a preparation method thereof. The antibacterial liquid provided by the invention adopts natural traditional Chinese medicines as raw material components, is green and safe, has the effects of inhibiting staphylococcus aureus, escherichia coli and candida albicans, can effectively treat various rhinitis, nasosinusitis and nasal polyp, can also treat influenza, common cold and various viral cold, can also prevent hysteria and toxic gas in four seasons, and has a certain curative effect on headache, traumatic injury and mosquito bite.
The invention aims to protect a bacteria inhibiting liquid, which comprises the following raw material components in parts by weight: 2-4 parts of centipeda minima, 2-4 parts of rhizoma atractylodis, 4-6 parts of honeysuckle, 4-6 parts of fructus forsythiae, 2-4 parts of flos magnoliae, 2-4 parts of litsea cubeba, 2-4 parts of peppermint, 3-4 parts of agilawood, 4-6 parts of radix sileris, 4-6 parts of herba schizonepetae, 2-4 parts of liquorice, 5-7 parts of chrysanthemum, 5-6 parts of dyers woad leaf, 4-6 parts of radix isatidis, 2-4 parts of lutein, 4-6 parts of radix astragali, 4-6 parts of radix tetrastigme, 4-6 parts of herba houttuyniae, 4-6 parts of fructus gardeniae, 12-18 parts of purified water, 3-5 parts of chlorhexidine acetate and 0.8-1.2 parts of borneol.
Preferably, the antibacterial liquid comprises the following raw material components in parts by weight: 3 parts of centipeda minima, 3 parts of rhizoma atractylodis, 5 parts of honeysuckle, 5 parts of fructus forsythiae, 3 parts of flos magnoliae, 3 parts of litsea cubeba, 3 parts of peppermint, 3.5 parts of agilawood, 5 parts of radix sileris, 5 parts of schizonepeta, 3 parts of liquorice, 6 parts of chrysanthemum, 5.5 parts of dyers woad leaf, 5 parts of radix isatidis, 3 parts of lutein, 5 parts of astragalus mongholicus, 5 parts of radix tetrastigme, 5 parts of houttuynia cordata, 5 parts of gardenia, 15 parts of purified water, 4 parts of chlorhexidine acetate and 1 part of borneol.
Preferably, the antibacterial liquid comprises the following raw material components in parts by weight: 2 parts of centipeda minima, 2 parts of rhizoma atractylodis, 4 parts of honeysuckle, 4 parts of fructus forsythiae, 2 parts of flos magnoliae, 2 parts of litsea cubeba, 2 parts of peppermint, 3 parts of agilawood, 4 parts of radix sileris, 4 parts of herba schizonepetae, 2 parts of liquorice, 5 parts of chrysanthemum, 5 parts of dyers woad leaf, 4 parts of radix isatidis, 2 parts of lutein, 4 parts of radix astragali, 4 parts of radix tetrastigme, 4 parts of cordate houttuynia, 4 parts of gardenia, 12 parts of purified water, 3 parts of chlorhexidine acetate and 0.8 part of borneol.
Preferably, the antibacterial liquid comprises the following raw material components in parts by weight: 4 parts of centipeda minima, 4 parts of rhizoma atractylodis, 6 parts of honeysuckle, 6 parts of fructus forsythiae, 4 parts of flos magnoliae, 4 parts of litsea cubeba, 4 parts of peppermint, 4 parts of agilawood, 6 parts of radix sileris, 6 parts of schizonepeta, 4 parts of liquorice, 7 parts of chrysanthemum, 6 parts of dyers woad leaf, 6 parts of radix isatidis, 4 parts of lutein, 6 parts of astragalus mongholicus, 6 parts of radix tetrastigme, 6 parts of houttuynia cordata, 6 parts of gardenia, 18 parts of purified water, 5 parts of chlorhexidine acetate and 1.2 parts of borneol.
The invention also aims at protecting the preparation method of the antibacterial liquid, which comprises the following steps:
s1, cleaning herba Centipedae, rhizoma Atractylodis, flos Lonicerae, fructus forsythiae, flos Magnoliae, fructus Litseae, herba Menthae, lignum Aquilariae Resinatum, radix Saposhnikoviae, herba Schizonepetae, glycyrrhrizae radix, flos Chrysanthemi, folium Isatidis, radix Isatidis, lutein, radix astragali, radix Apioris Fortunei, herba Houttuyniae and fructus Gardeniae, oven drying, pulverizing, and sieving to obtain mixed powder A;
s2, mixing borneol, lutein and chlorhexidine hydrochloride, grinding, and sieving to obtain mixed powder B;
s3, adding an ethanol solution with the concentration of 95% into the mixed medicine powder A, carrying out ultrasonic constant-temperature water bath, soaking, filtering, concentrating the filtrate until no ethanol exists, and filtering again to obtain a mixed medicine extract A;
s4, adding the mixed powder B and purified water into the mixed medicine extract A, and uniformly stirring to obtain the antibacterial liquid.
Preferably, in step S1, the drying is performed at 50-60 ℃ for 4-6 hours.
Preferably, in step S1, the baking is performed at 150-210 ℃ for 20-30min.
Preferably, in step S1, the sieving is a 200 mesh sieve.
Preferably, in step S2, the sieving is a 200 mesh sieve.
Preferably, in step S3, the weight part ratio of the mixed powder a to the ethanol solution is 1:6, preparing a base material; the ultrasonic constant temperature water bath is carried out for 60 minutes under the conditions of 60 ℃ and 50 Hz ultrasonic frequency; the soaking is carried out for 20 hours at 25 ℃.
The beneficial effects of the invention are as follows:
(1) The antibacterial liquid provided by the invention adopts natural traditional Chinese medicines as raw material components, is green and safe, has the effects of inhibiting staphylococcus aureus, escherichia coli and candida albicans, can effectively treat various rhinitis, nasosinusitis and nasal polyp, can also treat influenza, common cold and various viral cold, can also prevent hysteria and toxic gas in four seasons, and has a certain curative effect on headache, traumatic injury and mosquito bite.
(2) The preparation method of the antibacterial liquid provided by the invention is simple to operate, stable in technology and easy to obtain raw materials, and the prepared product has excellent effect and great popularization value.
Detailed Description
Embodiments of the technical scheme of the present invention will be described in detail below. The following examples are only for more clearly illustrating the technical aspects of the present invention, and thus are merely examples, and are not intended to limit the scope of the present invention.
It is noted that unless otherwise indicated, technical or scientific terms used herein should be given the ordinary meaning as understood by one of ordinary skill in the art to which this invention pertains.
Example 1
The embodiment provides a bacteriostatic liquid, which comprises the following raw material components in parts by weight: 3 parts of centipeda minima, 3 parts of rhizoma atractylodis, 5 parts of honeysuckle, 5 parts of fructus forsythiae, 3 parts of flos magnoliae, 3 parts of litsea cubeba, 3 parts of peppermint, 3.5 parts of agilawood, 5 parts of radix sileris, 5 parts of schizonepeta, 3 parts of liquorice, 6 parts of chrysanthemum, 5.5 parts of dyers woad leaf, 5 parts of radix isatidis, 3 parts of lutein, 5 parts of astragalus mongholicus, 5 parts of radix tetrastigme, 5 parts of houttuynia cordata, 5 parts of gardenia, 15 parts of purified water, 4 parts of chlorhexidine acetate and 1 part of borneol.
The embodiment also provides a preparation method of the antibacterial liquid, which comprises the following steps:
s1, cleaning herba Centipedae, rhizoma Atractylodis, flos Lonicerae, fructus forsythiae, flos Magnoliae, fructus Litseae, herba Menthae, lignum Aquilariae Resinatum, radix Saposhnikoviae, herba Schizonepetae, glycyrrhrizae radix, flos Chrysanthemi, folium Isatidis, radix Isatidis, lutein, radix astragali, radix Apioris Fortunei, herba Houttuyniae and fructus Gardeniae, oven drying, pulverizing, and sieving to obtain mixed powder A;
s2, mixing borneol, lutein and chlorhexidine hydrochloride, grinding, and sieving to obtain mixed powder B;
s3, adding an ethanol solution with the concentration of 95% into the mixed medicine powder A, carrying out ultrasonic constant-temperature water bath, soaking, filtering, concentrating the filtrate until no ethanol exists, and filtering again to obtain a mixed medicine extract A;
s4, adding the mixed powder B and purified water into the mixed medicine extract A, and uniformly stirring to obtain the antibacterial liquid.
In step S1, the drying is carried out at 55 ℃ for 5 hours.
In step S1, the baking is performed at 180 ℃ for 25min.
In step S1, sieving is carried out by a 200-mesh sieve.
In step S2, sieving is carried out by a 200-mesh sieve.
In the step S3, the weight part ratio of the mixed powder A to the ethanol solution is 1:6, preparing a base material; the ultrasonic constant-temperature water bath is carried out for 60 minutes under the conditions of 60 ℃ and 50 Hz ultrasonic frequency; soaking at 25deg.C for 20 hr.
Example 2
The embodiment provides a bacteriostatic liquid, which comprises the following raw material components in parts by weight: 2 parts of centipeda minima, 2 parts of rhizoma atractylodis, 4 parts of honeysuckle, 4 parts of fructus forsythiae, 2 parts of flos magnoliae, 2 parts of litsea cubeba, 2 parts of peppermint, 3 parts of agilawood, 4 parts of radix sileris, 4 parts of herba schizonepetae, 2 parts of liquorice, 5 parts of chrysanthemum, 5 parts of dyers woad leaf, 4 parts of radix isatidis, 2 parts of lutein, 4 parts of radix astragali, 4 parts of radix tetrastigme, 4 parts of cordate houttuynia, 4 parts of gardenia, 12 parts of purified water, 3 parts of chlorhexidine acetate and 0.8 part of borneol.
The embodiment also provides a preparation method of the antibacterial liquid, which comprises the following steps:
s1, cleaning herba Centipedae, rhizoma Atractylodis, flos Lonicerae, fructus forsythiae, flos Magnoliae, fructus Litseae, herba Menthae, lignum Aquilariae Resinatum, radix Saposhnikoviae, herba Schizonepetae, glycyrrhrizae radix, flos Chrysanthemi, folium Isatidis, radix Isatidis, lutein, radix astragali, radix Apioris Fortunei, herba Houttuyniae and fructus Gardeniae, oven drying, pulverizing, and sieving to obtain mixed powder A;
s2, mixing borneol, lutein and chlorhexidine hydrochloride, grinding, and sieving to obtain mixed powder B;
s3, adding an ethanol solution with the concentration of 95% into the mixed medicine powder A, carrying out ultrasonic constant-temperature water bath, soaking, filtering, concentrating the filtrate until no ethanol exists, and filtering again to obtain a mixed medicine extract A;
s4, adding the mixed powder B and purified water into the mixed medicine extract A, and uniformly stirring to obtain the antibacterial liquid.
In step S1, the drying is carried out at 55 ℃ for 5 hours.
In step S1, the baking is performed at 180 ℃ for 25min.
In step S1, sieving is carried out by a 200-mesh sieve.
In step S2, sieving is carried out by a 200-mesh sieve.
In the step S3, the weight part ratio of the mixed powder A to the ethanol solution is 1:6, preparing a base material; the ultrasonic constant-temperature water bath is carried out for 60 minutes under the conditions of 60 ℃ and 50 Hz ultrasonic frequency; soaking at 25deg.C for 20 hr.
Example 3
The embodiment provides a bacteriostatic liquid, which comprises the following raw material components in parts by weight: 4 parts of centipeda minima, 4 parts of rhizoma atractylodis, 6 parts of honeysuckle, 6 parts of fructus forsythiae, 4 parts of flos magnoliae, 4 parts of litsea cubeba, 4 parts of peppermint, 4 parts of agilawood, 6 parts of radix sileris, 6 parts of schizonepeta, 4 parts of liquorice, 7 parts of chrysanthemum, 6 parts of dyers woad leaf, 6 parts of radix isatidis, 4 parts of lutein, 6 parts of astragalus mongholicus, 6 parts of radix tetrastigme, 6 parts of houttuynia cordata, 6 parts of gardenia, 18 parts of purified water, 5 parts of chlorhexidine acetate and 1.2 parts of borneol.
The embodiment also provides a preparation method of the antibacterial liquid, which comprises the following steps:
s1, cleaning herba Centipedae, rhizoma Atractylodis, flos Lonicerae, fructus forsythiae, flos Magnoliae, fructus Litseae, herba Menthae, lignum Aquilariae Resinatum, radix Saposhnikoviae, herba Schizonepetae, glycyrrhrizae radix, flos Chrysanthemi, folium Isatidis, radix Isatidis, lutein, radix astragali, radix Apioris Fortunei, herba Houttuyniae and fructus Gardeniae, oven drying, pulverizing, and sieving to obtain mixed powder A;
s2, mixing borneol, lutein and chlorhexidine hydrochloride, grinding, and sieving to obtain mixed powder B;
s3, adding an ethanol solution with the concentration of 95% into the mixed medicine powder A, carrying out ultrasonic constant-temperature water bath, soaking, filtering, concentrating the filtrate until no ethanol exists, and filtering again to obtain a mixed medicine extract A;
s4, adding the mixed powder B and purified water into the mixed medicine extract A, and uniformly stirring to obtain the antibacterial liquid.
In step S1, the drying is carried out at 55 ℃ for 5 hours.
In step S1, the baking is performed at 180 ℃ for 25min.
In step S1, sieving is carried out by a 200-mesh sieve.
In step S2, sieving is carried out by a 200-mesh sieve.
In the step S3, the weight part ratio of the mixed powder A to the ethanol solution is 1:6, preparing a base material; the ultrasonic constant-temperature water bath is carried out for 60 minutes under the conditions of 60 ℃ and 50 Hz ultrasonic frequency; soaking at 25deg.C for 20 hr.
Test examples
The antibacterial property of the antibacterial liquid prepared in examples 1 to 3 was tested, and the results are shown in Table 1.
TABLE 1
From Table 1, it is clear that the antibacterial liquid provided by the invention can inhibit Staphylococcus aureus, escherichia coli and Candida albicans with high efficiency.
Finally, it should be noted that: the above embodiments are only for illustrating the technical solution of the present invention, and not for limiting the same; although the invention has been described in detail with reference to the foregoing embodiments, it will be understood by those of ordinary skill in the art that: the technical scheme described in the foregoing embodiments can be modified or some or all of the technical features thereof can be replaced by equivalents; such modifications and substitutions do not depart from the spirit of the invention, and are intended to be included within the scope of the appended claims and description.
Claims (10)
1. A bacteriostatic liquid, which is characterized in that: the antibacterial liquid comprises the following raw material components in parts by weight: 2-4 parts of centipeda minima, 2-4 parts of rhizoma atractylodis, 4-6 parts of honeysuckle, 4-6 parts of fructus forsythiae, 2-4 parts of flos magnoliae, 2-4 parts of litsea cubeba, 2-4 parts of peppermint, 3-4 parts of agilawood, 4-6 parts of radix sileris, 4-6 parts of herba schizonepetae, 2-4 parts of liquorice, 5-7 parts of chrysanthemum, 5-6 parts of dyers woad leaf, 4-6 parts of radix isatidis, 2-4 parts of lutein, 4-6 parts of radix astragali, 4-6 parts of radix tetrastigme, 4-6 parts of herba houttuyniae, 4-6 parts of fructus gardeniae, 12-18 parts of purified water, 3-5 parts of chlorhexidine acetate and 0.8-1.2 parts of borneol.
2. The bacteria inhibiting liquid of claim 1, wherein: the antibacterial liquid comprises the following raw material components in parts by weight: 3 parts of centipeda minima, 3 parts of rhizoma atractylodis, 5 parts of honeysuckle, 5 parts of fructus forsythiae, 3 parts of flos magnoliae, 3 parts of litsea cubeba, 3 parts of peppermint, 3.5 parts of agilawood, 5 parts of radix sileris, 5 parts of schizonepeta, 3 parts of liquorice, 6 parts of chrysanthemum, 5.5 parts of dyers woad leaf, 5 parts of radix isatidis, 3 parts of lutein, 5 parts of astragalus mongholicus, 5 parts of radix tetrastigme, 5 parts of houttuynia cordata, 5 parts of gardenia, 15 parts of purified water, 4 parts of chlorhexidine acetate and 1 part of borneol.
3. The bacteria inhibiting liquid of claim 1, wherein: the antibacterial liquid comprises the following raw material components in parts by weight: 2 parts of centipeda minima, 2 parts of rhizoma atractylodis, 4 parts of honeysuckle, 4 parts of fructus forsythiae, 2 parts of flos magnoliae, 2 parts of litsea cubeba, 2 parts of peppermint, 3 parts of agilawood, 4 parts of radix sileris, 4 parts of herba schizonepetae, 2 parts of liquorice, 5 parts of chrysanthemum, 5 parts of dyers woad leaf, 4 parts of radix isatidis, 2 parts of lutein, 4 parts of radix astragali, 4 parts of radix tetrastigme, 4 parts of cordate houttuynia, 4 parts of gardenia, 12 parts of purified water, 3 parts of chlorhexidine acetate and 0.8 part of borneol.
4. The bacteria inhibiting liquid of claim 1, wherein: the antibacterial liquid comprises the following raw material components in parts by weight: 4 parts of centipeda minima, 4 parts of rhizoma atractylodis, 6 parts of honeysuckle, 6 parts of fructus forsythiae, 4 parts of flos magnoliae, 4 parts of litsea cubeba, 4 parts of peppermint, 4 parts of agilawood, 6 parts of radix sileris, 6 parts of schizonepeta, 4 parts of liquorice, 7 parts of chrysanthemum, 6 parts of dyers woad leaf, 6 parts of radix isatidis, 4 parts of lutein, 6 parts of astragalus mongholicus, 6 parts of radix tetrastigme, 6 parts of houttuynia cordata, 6 parts of gardenia, 18 parts of purified water, 5 parts of chlorhexidine acetate and 1.2 parts of borneol.
5. A method for preparing the antibacterial liquid according to any one of claims 1 to 4, characterized in that: the preparation method of the antibacterial liquid comprises the following steps:
s1, cleaning herba Centipedae, rhizoma Atractylodis, flos Lonicerae, fructus forsythiae, flos Magnoliae, fructus Litseae, herba Menthae, lignum Aquilariae Resinatum, radix Saposhnikoviae, herba Schizonepetae, glycyrrhrizae radix, flos Chrysanthemi, folium Isatidis, radix Isatidis, lutein, radix astragali, radix Apioris Fortunei, herba Houttuyniae and fructus Gardeniae, oven drying, pulverizing, and sieving to obtain mixed powder A;
s2, mixing borneol, lutein and chlorhexidine hydrochloride, grinding, and sieving to obtain mixed powder B;
s3, adding an ethanol solution with the concentration of 95% into the mixed medicine powder A, carrying out ultrasonic constant-temperature water bath, soaking, filtering, concentrating the filtrate until no ethanol exists, and filtering again to obtain a mixed medicine extract A;
s4, adding the mixed powder B and purified water into the mixed medicine extract A, and uniformly stirring to obtain the antibacterial liquid.
6. The method for preparing the antibacterial liquid according to claim 5, wherein: in the step S1, the drying is carried out for 4-6 hours at 50-60 ℃.
7. The method for preparing the antibacterial liquid according to claim 5, wherein: in the step S1, the baking is performed at 150-210 ℃ for 20-30min.
8. The method for preparing the antibacterial liquid according to claim 5, wherein: in step S1, the sieving is that a 200-mesh sieve is adopted.
9. The method for preparing the antibacterial liquid according to claim 5, wherein: in step S2, the sieving is that a 200-mesh sieve is adopted.
10. The method for preparing the antibacterial liquid according to claim 5, wherein: in the step S3, the weight part ratio of the mixed powder A to the ethanol solution is 1:6, preparing a base material; the ultrasonic constant temperature water bath is carried out for 60 minutes under the conditions of 60 ℃ and 50 Hz ultrasonic frequency; the soaking is carried out for 20 hours at 25 ℃.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310673872.3A CN116531447A (en) | 2023-06-08 | 2023-06-08 | Antibacterial liquid and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310673872.3A CN116531447A (en) | 2023-06-08 | 2023-06-08 | Antibacterial liquid and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116531447A true CN116531447A (en) | 2023-08-04 |
Family
ID=87450823
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310673872.3A Pending CN116531447A (en) | 2023-06-08 | 2023-06-08 | Antibacterial liquid and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116531447A (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1686191A (en) * | 2005-01-06 | 2005-10-26 | 范宏智 | Anticommon cold Chinese medicine breathing mask |
CN103223019A (en) * | 2013-04-04 | 2013-07-31 | 施怀杰 | Traditional Chinese medicine for treating rhinitis |
CN104056119A (en) * | 2014-06-20 | 2014-09-24 | 黄方柱 | Health care wine and preparation method thereof |
CN107753631A (en) * | 2017-12-20 | 2018-03-06 | 谢宏林 | A kind of Rhinitis treating medicinal cream of antibacterial sterilization and preparation method thereof |
CN110613827A (en) * | 2019-10-22 | 2019-12-27 | 赵克正 | Bacteriostatic spray and preparation method thereof |
CN110638915A (en) * | 2019-10-24 | 2020-01-03 | 湖南省太阳殿生物科技有限公司 | Traditional Chinese medicine composition for treating chronic rhinitis and preparation method thereof |
CN111134148A (en) * | 2020-02-06 | 2020-05-12 | 宋小冰 | Traditional Chinese medicine aromatherapy air disinfectant |
-
2023
- 2023-06-08 CN CN202310673872.3A patent/CN116531447A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1686191A (en) * | 2005-01-06 | 2005-10-26 | 范宏智 | Anticommon cold Chinese medicine breathing mask |
CN103223019A (en) * | 2013-04-04 | 2013-07-31 | 施怀杰 | Traditional Chinese medicine for treating rhinitis |
CN104056119A (en) * | 2014-06-20 | 2014-09-24 | 黄方柱 | Health care wine and preparation method thereof |
CN107753631A (en) * | 2017-12-20 | 2018-03-06 | 谢宏林 | A kind of Rhinitis treating medicinal cream of antibacterial sterilization and preparation method thereof |
CN110613827A (en) * | 2019-10-22 | 2019-12-27 | 赵克正 | Bacteriostatic spray and preparation method thereof |
CN110638915A (en) * | 2019-10-24 | 2020-01-03 | 湖南省太阳殿生物科技有限公司 | Traditional Chinese medicine composition for treating chronic rhinitis and preparation method thereof |
CN111134148A (en) * | 2020-02-06 | 2020-05-12 | 宋小冰 | Traditional Chinese medicine aromatherapy air disinfectant |
Non-Patent Citations (3)
Title |
---|
无: "预防非典型肺炎中医药处方精萃", 河北中医, vol. 25, no. 05, 28 May 2003 (2003-05-28), pages 328 * |
达木索, 等: "中西医结合治疗慢性化脓性副鼻窦炎80例疗效观察", 新中医, vol. 36, no. 04, 5 April 2004 (2004-04-05), pages 51 - 52 * |
郑州轩仲堂生物科技有限公司企业标准: "抑菌液", pages 3, Retrieved from the Internet <URL:https://www.qybz.org.cn/user/pdfDetail/e1ae89a8d09548c6901a5e5bd53f8e68?geetest_challenge=73fb96a1d1a5c8ee3e66c5ef98fc53b3ae&geetest_validate=d710a6e3eff65faa76546a90023652c1&geetest_seccode=d710a6e3eff65faa76546a90023652c1|jordan> * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101336991B (en) | Medicine for treating gynaecologic pruritus vulvae and colpitis | |
CN105727236A (en) | Powder for treating red skin disease of osphronemus goramy and preparation method thereof | |
CN111067935A (en) | Rhinitis medicine and preparation method thereof | |
CN106046804A (en) | Energy-saving environment-friendly LED ceiling lamp | |
CN1270765C (en) | Medicinal wine or liquid for treating cold | |
CN101073616A (en) | Compound nebula for treating rhinitis | |
CN116531447A (en) | Antibacterial liquid and preparation method thereof | |
CN104306712A (en) | Heat clearing and detoxifying tea and preparation method thereof | |
CN106122796A (en) | LED spotlight with convection heat dissipation function | |
CN108853221A (en) | A kind of drug and preparation method thereof for preventing and treating newcastle disease | |
CN1931331A (en) | Chinese medicine composition for treating hepatitis B and its prepn process | |
CN108066588B (en) | Traditional Chinese medicine composition for treating rhinitis, external patch and preparation method thereof | |
CN106221242A (en) | LED down lamp with air convection heat dissipation function | |
CN112386629A (en) | Spray for treating rhinitis and relieving cold symptoms and preparation method thereof | |
CN104645016A (en) | Traditional Chinese medicine spray for treating oral and laryngeal diseases | |
CN103599205B (en) | Traditional Chinese medicine liquid of control wound infection and preparation method thereof | |
CN104306761A (en) | Granules for treating cold and preparation method thereof | |
CN1188658A (en) | 'Lanweiling' oral liquid for treating appendicitis | |
CN116808148B (en) | Skin itching relieving lotion and preparation method thereof | |
CN111202778A (en) | A topical Chinese medicinal composition for treating fever due to influenza and viral infection | |
CN103623050A (en) | Traditional Chinese medicinal prescription of eye ointment | |
CN104352778A (en) | Pharmaceutical composition for treating acute laryngitis of dogs and preparation method thereof | |
CN112262904A (en) | Yao medicine tea for treating cold and preparation method thereof | |
CN111729041A (en) | A Chinese medicinal composition for treating burn and scald, and its preparation method | |
CN112057566A (en) | Traditional Chinese medicine composition for treating meniere disease and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |